This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Cross Therapy Registry - Edema - US

Sponsored by Firstkind Ltd

About this trial

Last updated 2 years ago

Study ID

FSK-REG-001-US

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Trial Timing

Ended a year ago

What is this trial about?

The geko™ Cross Therapy Registry - Edema (gekoTM CTR - Edema) study will prospectively and systematically collect clinical data on all device variants used in standard care pathways for edema management allowing for the monitoring of patient outcomes during a follow-up period of up to twelve months.

What are the participation requirements?

Yes

Inclusion Criteria

- Male or female aged ≥ 18 years and able to provide written informed consent.

- Intact healthy skin at the site of gekoTM device application.

- Subjects receiving gekoTM therapy as part of their standard care for edema reduction.

No

Exclusion Criteria

- Pregnancy or breast feeding.

- Use of any concurrent neuro-modulation device.

- Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve.

- No involuntary movement of the lower leg/foot at the maximum tolerable device setting.

- Bilateral lower limb surgical intervention.

- Unicondylar knee replacement surgical intervention.

Locations

Location

Status

Recruiting
Completed
Completed